ClaudioA.BenadivaMDHCLD

PubMed

• Defects in meiosis I contribute to the genesis of androgenetic hydatidiform moles.
  Maryam Rezaei, Manqi Liang, Zeynep Yalcin, Jacinta H Martin, Parinaz Kazemi
  The Journal of Clinical Investigation. 2024-11-15
• The impact of microfluidics sperm processing on blastocyst euploidy rates compared with density gradient centrifugation: a sibling oocyte double-blinded prospective ra...
  Prachi Godiwala, Jane Kwieraga, Emilse Almanza, Evelyn Neuber, Daniel Grow
  Fertility and Sterility. 2024-07-01
• 2 citations
  Macroprolactinemia: a mini-review and update on clinical practice.
  Katherine Koniares, Claudio Benadiva, Lawrence Engmann, John Nulsen, Daniel Grow
  F&S Reports. 2023-09-01

Journal Articles

• Optimal usage of the GnRH antagonists: a review of the literature.  
  Copperman A and Benadiva CA, Reprod Biology and Endocrinology, 2013, 11:20
• Prospective pilot study comparing fertilization and embryo development between fresh and vitrified sibling oocytes.  
  Siano L, Nulsen J, Engmann L and Benadiva CA, Connecticut Medicine, 2013, 77:211-8

Books/Book Chapters

• Operative Laparoscopy. 
  Chapter: Assisted reproductive technologies versus tubal surgery 
  Page 278 - 308Benadiva CA, Kligman I, Rosenwaks ZEditors: Sanfilippo JS.Springer-Verlag, New YorkEdition 2,
• Gynecologic Surgery. 
  Chapter: Tubal Reconstructive Surgery 
  Page 609 - 630Rosenwaks Z, Kligman I, Benadiva CA, Davis OEditors: Mann WJ and Stovall TG.Churchill-Livingston, New York
• Manual of Ovulation Induction. 
  Chapter: Step-up protocols 
  Page 51 - 57Bremner T, Benadiva CAEditors: Gautam Allahbadia.Rotunda Medical Technologies, Bombay, India
• Infertility and Reproductive Medicine Clinics of North America. 
  Chapter: Preimplantation genetic diagnosis and assisted reproduction 
  Page 489 - 505Benadiva C, Orris JJ
• Infertility and Reproductive Medicine Clinics of North America. 
  Chapter: Prevention strategies for ovarian hyperstimulation syndrome 
  Page 459 - 474Orris JJ, Nulsen JC, Benadiva CA
• The Art and Science of Assisted Reproductive Techniques. 
  Chapter: Defining the poor ovarian response before controlled ovarian hyperstimulation 
  Page 34 - 46Schmidt D, Benadiva CAEditors: Gautam Allahbadia and Rita Basuray.Jaypee Brothers Medical Publishers LtdEdition 1,
• Reproduccion Humana e Infertilidad. 
  Chapter: nduccion de la ovulacion para procedimientos de alta complejidad 
  Page 423 - 429Sueldo C, Nabel A, Glujovsky D, Sueldo C, Engmann L and Benadiva CAEditors: Antonio Mackenna.Editorial Mediterraneo, Santiago Chile
• Join now to see all

Abstracts/Posters

• Human oocytes express Gs G-Protein and the G-Protein-coupled receptor GPR3, key components in the maintenance of meiotic arrest in mouse.
  DiLuigi A, Maier DB, Nulsen JC, Benadiva CA, Schmidt D and Mehlmann LM, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• Selection of first IVF cycle stimulation protocol for good prognosis patients: GnRH antagonist vs. agonist protocols.
  Johnston-MacAnanny EB, Di Luigi A, Engmann L, Maier DB, Benadiva CA, and Nulsen JC, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Elective single blastocyst transfer in a selected group of patients does not adversely affect the probability of conception and reduces the probability of twin gestation.
  Engmann L, Siano L, Schmidt DW, Benadiva CA, Maier DB and Nulsen JC, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Choice of medication for oocyte maturation for IVF GnRH antagonist cycles: hCG vs Leuprolide acetate.
  Johnston-MacAnanny EB, Di Luigi AJ, Benadiva CA, Maier DB, Nulsen JC and Engmann L, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Elective cryopreservation of all embryos after GnRH agonist trigger is not justified because of the comparable success rates between fresh and cryo-thawed embryo trans...
  LaMonica R, Siano LJ, Nulsen JC, Maier DB, Benadiva CA and Engmann L, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• The in vitro viability, steroidogenic, and VEGF secretory capacity of human luteinized granulosa cells after GnRH agonist trigger.
  Engmann L, Benadiva CA, Romak JJ, Nulsen JC, Maier DB, Peluso JJ, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• GnRH agonist triggers: do subsequent estradiol and progesterone levels predict pregnancy?
  Johnston-MacAnanny EB, Benadiva CA, Siano LJ, Nulsen JC, Maier DB, and Engmann L, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Luteal phase circulating VEGF, estradiol and progesterone levels after GnRH agonist trigger.
  Engmann L, Romak JJ, Nulsen JC, Maier DB, Peluso JJ, and Benadiva CA, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Leuprolide Acetate trigger effectively prevents OHSS without compromising clinical outcomes in patients with serum estradiol >4,000 pg/ml in IVF cycles.
  DiLuigi AJ, Engmann L, Siano LJ, Maier DB, Nulsen JC, and Benadiva CA, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation versus standard microdose...
  Weitzman V, Engmann L, DiLuigi A, Nulsen JC, Maier DB, and Benadiva CA, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• Immunohystochemistry confirms the presence of chronic endometritis in patients with recurrent implantation failure.
  LaMonica R, Hartnett JM, Engmann L, Sanders MM, Maier DB, and Benadiva CA, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• Evaluation of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation in patients with a histor...
  Weitzman V, Engmann L, DiLuigi A, Nulsen JC, Maier DB, and Benadiva CA, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• The role of endometrial function test in recurrent implantation failure in IVF.
  Johnston-MacAnanny EB, Kliman HJ, Maier DB, Nulsen JC and Benadiva CA, American Society for Reproductive Medicine 63rd Annual Meeting, Washington DC
• Embryos not meeting criteria for freezing at the multicellular stage can result in blastocysts with implantation and pregnancy rates comparable to multicellular embryo...
  DiLuigi A, Siano L, Engmann L, Nulsen JC, Benadiva CA and Maier DB, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles.
  Berin I, Engmann L, Benadiva CA, Schmidt D, Nulsen JC and Maier DB, American Society for Reproductive Medicine 62nd Annual Meeting, New Orleans
• Should in vitro fertilization cycles be canceled in women 40 years of age and older who produce four or less oocytes?
  DiLuigi A, Schmidt D, Nulsen JC, Maier DB and Benadiva CA, Conjoint Meeting of the American Society for Reproductive Medicine 61st Annual Meeting, Canadian Fertility and Andrology Society 51st Annual Meeting, Montreal, Canada
• Serum estradiol level on day of embryo transfer is associated with implantation and pregnancy rates.
  DiLuigi A, Schmidt D, Benadiva CA, Maier DB and Nulsen JC, Conjoint Meeting of the American Society for Reproductive Medicine 61st Annual Meeting, Canadian Fertility and Andrology Society 51st Annual Meeting, Montreal, Canada
• A prospective randomized trial evaluating the effect of luteal phase estradiol supplementation on the success of IVF treatment.
  Engmann L, DiLuigy A, Schmidt D, Benadiva CA, Maier DB and Nulsen JC, Conjoint Meeting of the American Society for Reproductive Medicine 61st Annual Meeting, Canadian Fertility and Andrology Society 51st Annual Meeting, Montreal, Canada
• The role of endometrial biopsy in the evaluation of recurrent implantation failure.
  Hartnett JM, Engmann L, Sanders MM, Maier DB, Nulsen JC, and Benadiva CA, Conjoint Meeting of the American Society for Reproductive Medicine 61st Annual Meeting, Canadian Fertility and Andrology Society 51st Annual Meeting, Montreal, Canada
• Prevention of OHSS with the use of GnRH agonist to trigger final oocyte maturation after cotreatment with GnRH antagonist in patients with PCOS or previous high respon...
  Engmann L, Schmidt D, Nulsen JC, Maier DB and Benadiva CA, Conjoint Meeting of the American Society for Reproductive Medicine 61st Annual Meeting, Canadian Fertility and Andrology Society 51st Annual Meeting, Montreal, Canada
• The probability of conception after embryo transfer using fresh or cryo-thawed multicellular embryos.
  Engmann L, Siano L, Schmidt D, Nulsen JC, Maier DB and Benadiva CA, Pacific Coast Reproductive Society Annual Meeting, Indian Wells, CA
• The use of GnRH agonist to trigger final stages of oocyte maturation in patients with PCOS and high responders during IVF treatment.
  Engmann L, Harnett L, Siano L, Schmidt D, Nulsen JC, Maier DB and Benadiva CA, Pacific Coast Reproductive Society Annual Meeting, Indian Wells, CA, May 4-8
• Septate Uterus.
  Duffy D, Nulsen JC, Maier D, Schmidt D and Benadiva CA, Danbury Hospital 19th Annual Joseph L. Belsky, M.D. Research Day. Connecticut Medicine, 68:568
• An unusual variation of a unicornuate uterus with a normal external uterine morphology.
  Engmann L, Schmidt D, Nulsen JC, Maier DB and Benadiva CA, 5th World Congress on Controversies in Obstetrics, Gynecology and Infertility, Las Vegas, NV
• Luteal phase estradiol (LP) versus luteal phase estradiol and antagonist (LPG) protocol for controlled ovarian stimulation prior to IVF in poor responders.
  Elassar A, Mann J, Engmann L, Schmidt D, Nulsen J and Benadiva CA, American Society for Reproductive Medicine 65th Annual Meeting, Atlanta, GA
• Join now to see all

Other

• GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. 
  Engmann L, and Benadiva CA, Letters-to-the –Editor, Hum Reprod, 20:3258-60
• Ovarian hyperstimulation syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ... 
  Engmann L and Benadiva CA, Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 506-12
• Ovarian hyperstimulation: a preventable syndrome? 
  Rosenwaks Z and Benadiva CA, Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 437-9
• An eye to the future. 
  Rosenwaks Z and Benadiva CA, Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 540
• Letrozole + GnRH antagonist protocol early LH rise and cost-effectiveness. 
  Elassar A, and Benadiva CA, Reply to Letters-to-the –Editor, Fertil Steril 2011, 9:e80
• GnRH agonist for triggering of final oocyte maturation: time for a critical evaluation of data. 
  Humaidan P, Kol S, Papanikolaou EG, Engmann L, Benadiva CA, Itskovitz-Eldor J, Margalioth EJ, Ricciarelly E, Bodri D, Castillo-Farfan JC, Garacia-Vezasco JA, Yding And..., Letters-to-the –Editor, Hum Reprod Update, 18 (2):229-230
• Intensive luteal phase support after GnRH agonist trigger: it does help. 
  Benadiva CA, Engmann L, Letters-to-the-Editor, RBOnline 2012, 25,329-330
• Join now to see all